MARKET

ENLV

ENLV

Enlivex Therapeutics Ltd
NASDAQ
0.8191
+0.0377
+4.82%
After Hours: 0.8200 +0.0009 +0.11% 16:34 01/06 EST
OPEN
0.7998
PREV CLOSE
0.7814
HIGH
0.8215
LOW
0.7600
VOLUME
257.91K
TURNOVER
--
52 WEEK HIGH
2.100
52 WEEK LOW
0.6600
MARKET CAP
194.44M
P/E (TTM)
-1.5018
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ENLV last week (1229-0102)?
Weekly Report · 1d ago
Weekly Report: what happened at ENLV last week (1222-1226)?
Weekly Report · 12/29/2025 10:16
Enlivex Therapeutics files to sell 212M ordinary shares for holders
TipRanks · 12/23/2025 21:40
Weekly Report: what happened at ENLV last week (1215-1219)?
Weekly Report · 12/22/2025 10:16
Enlivex Calls February 2026 Extraordinary Meeting to Approve Governance Changes and Reverse Share Split
TipRanks · 12/18/2025 22:04
Weekly Report: what happened at ENLV last week (1208-1212)?
Weekly Report · 12/15/2025 10:22
Enlivex: A Necessary Update - This Is No Longer The Company We Covered In 2022
Seeking Alpha · 12/13/2025 09:11
Weekly Report: what happened at ENLV last week (1201-1205)?
Weekly Report · 12/08/2025 10:21
More
About ENLV
Enlivex Therapeutics Ltd is an Israel-based clinical stage macrophage reprogramming immunotherapy company developing Allocetra, off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. AllocetraTM is a therapy designed to reprogram macrophages into their homeostatic state. Diseases such as solid cancers, sepsis, COVID-19 and many others reprogram macrophages out of their homeostatic state. These non-homeostatic macrophages contribute significantly to the severity of the respective diseases. By restoring macrophage homeostasis, AllocetraTM has the potential to provide immunotherapeutic mechanism of action for life-threatening clinical indications that are defined as unmet medical needs, as a stand-alone therapy or in combination with therapeutic agents.

Webull offers Enlivex Therapeutics Ltd stock information, including NASDAQ: ENLV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENLV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ENLV stock methods without spending real money on the virtual paper trading platform.